Walker Walking

CANCER FUNDS

To achieve global impact, a scientific research institute requires world-class people, platforms and programs. The Campbell Family Cancer Research Institute at Princess Margaret Cancer Centre is fortunate that many top scientists have left their homes to come to Toronto because they believe that this is where they can have the most impact.

The Institute is building world-class research programs utilizing our expertise in the scientific platforms most vital for cancer research: mass spectrometry, flow cytometry, new drug discovery, genetic sequencing, biobanking and computational biology.

Breast cancer is the second leading cause of cancer death in Canadian females, accounting for 13 per cent of all female cancer deaths. 1 in 8 Canadian women are expected to develop breast cancer in their lifetime and 1 in 31 will die from it.

In 2017, it is estimated that:

  • 1,550 Canadian women will be diagnosed with cervical cancer
  • 7,300 will be diagnosed with uterine cancer
  • 2,800 will be diagnosed with ovarian cancer

The most recent incidence statistics for other and unspecified female genital organ cancers are from 2013:

  • 955 Canadian women were diagnosed with other and unspecified female genital organ cancers

The most recent mortality statistics for other and unspecified female genital organ cancers are from 2013:

  • 280 Canadian women died from other and unspecified female genital organ cancers

Colon, Rectal and Gastrointestinal Cancers

26,800 Canadians will be diagnosed with colorectal cancer in 2017, representing approximately 13 per cent of all new cancer cases in 2017.

  • 14,900 men will be diagnosed with colorectal cancer and 5,100 will die from it.
  • 11,900 women will be diagnosed with colorectal cancer and 4,300 will die from it

It is estimated that in 2017, 3,500 Canadians will be diagnosed with stomach cancer.

  • 2,200 men will be diagnosed with stomach cancer and 1,250 will die from it.
  • 1,300 women will be diagnosed with stomach cancer and 790 will die from it.

The five-year relative survival for stomach cancer is 25 per cent. This means that, on average, people diagnosed with stomach cancer are 25 per cent as likely to live 5 years (or more) after diagnosis as people in the general population who do not have cancer.

Prostate, Testicular, Bladder, Kidney and Genitourinary Cancers

Prostate Cancer:

21,300 men will be diagnosed with prostate cancer. This represents 21 per cent of all new cancer cases in men in 2017. 4,100 men will die from prostate cancer. This represents 10 per cent of all cancer deaths in men in 2017.

  • On average, 58 Canadian men will be diagnosed with prostate cancer every day
  • On average, 11 Canadian men will die from prostate cancer every day

Prostate cancer is the most common type of cancer among Canadian men, excluding non-melanoma skin cancer.

Testicular Cancer:

  • An estimated 1,100 Canadian men will be diagnosed with testicular cancer in 2017
  • An estimated 45 will die from the disease

Bladder:

It is estimated that in 2017:

  • 8,900 Canadians will be diagnosed with bladder cancer and 2,400 Canadians will die from bladder cancer
  • 6,700 men will be diagnosed with bladder cancer and 1,700 will die from it
  • 2,200 women will be diagnosed with bladder cancer and 680 will die from it

Kidney Cancer:

It is estimated that in 2017, 6,600 Canadians will be diagnosed with kidney cancer.

  • 4,200 men will be diagnosed with kidney cancer and 1,200 will die from it
  • 2,400 women will be diagnosed with kidney cancer and 670 will die from it

It is estimated that in 2017:

  • 5,500 Canadians will be diagnosed with pancreatic cancer
  • 4,800 Canadians will die from pancreatic cancer
  • 2,800 men will be diagnosed with pancreatic cancer and 2,400 will die from it
  • 2,700 women will be diagnosed with pancreatic cancer and 2,400 will die from it

Pancreatic cancer is the fourth leading cause of cancer death in both sexes accounting for 6 per cent of all cancer deaths.

In Canada, the five-year net survival for pancreatic cancer is eight per cent. This means that, on average, about eight per cent of people diagnosed with pancreatic cancer will survive for at least five years.

Head & Neck Cancers – Brain, Central Nervous System, and Eye

It is estimated that in 2017:

  • 3,000 Canadians will be diagnosed with brain and spinal cord cancer
  • 2,400 Canadians will die from brain and spinal cord cancer
  • 1,700 men will be diagnosed with brain and spinal cord cancer and 1,350 will die from it
  • 1,300 women will be diagnosed with brain and spinal cord cancer and 1,050 will die from it
  • An estimated 55,000 Canadians are living with brain tumours

Eye cancer is rare. From 2013, approximately 335 Canadians are diagnosed with eye cancer:

  • 175 men were diagnosed with eye cancer
  • 160 women were diagnosed with eye cancer

Skin Cancer & Melanoma

It is estimated that in 2017, 7,200 Canadians will be diagnosed with melanoma.

  • 4,000 men will be diagnosed with melanoma
  • 3,300 women will be diagnosed with melanoma
  • 80-90 per cent of skin cancer cases are caused by ultraviolet radiation

Endocrine Cancer

In 2010, 135 Canadians died from endocrine system related cancers. Because these cancers are so rare, prognosis is not well known.

Lymphoma

It is estimated that in 2017:

  • 990 Canadians will be diagnosed with Hodgkin lymphoma
  • 140 Canadians will die from Hodgkin lymphoma
  • 570 men will be diagnosed with Hodgkin lymphoma and 85 will die from it
  • 430 women will be diagnosed with Hodgkin lymphoma and 60 will die from it

It is estimated that in 2017:

  • 8,300 Canadians will be diagnosed with non-Hodgkin lymphoma
  • 2,700 Canadians will die from non-Hodgkin lymphoma
  • 4,600 men will be diagnosed with non-Hodgkin lymphoma and 1,500 will die from it
  • 3,700 women will be diagnosed with non-Hodgkin lymphoma and 1,200 will die from it

Leukaemia

It is estimated that in 2017:

  • 6,200 Canadians will be diagnosed with leukaemia
  • 2,900 Canadians will die from leukaemia
  • 3,600 men will be diagnosed with leukaemia and 1,650 will die from it
  • 2,600 women will be diagnosed with leukaemia and 1,250 will die from it

Childhood cancer accounts for less than one per cent of all new cancer cases in Canada.

The three types of cancer that account for the majority of new cancer cases in children 0 to 14 years of age in Canada are:

  • Leukaemia – 32 per cent
  • Brain and central nervous system – 19 per cent
  • Lymphomas – 11 per cent

The three types of cancer that account for the majority of cancer death in children 0 to 14 years of age in Canada are:

  • Brain and central nervous system – 34 per cent
  • Leukaemia – 26 per cent
  • Neuroblastoma and other peripheral nervous cell tumours – 11 per cent

Childhood cancer is relatively uncommon. However, it remains the most common disease-related cause of death more than asthma, diabetes, cystic fibrosis and AIDS combined. It is second only to injury-related deaths among Canadian children. In 2012, cancer was the leading cause of disease-related death in children under the age of 15 years.

Between 2009 and 2013, there were 4,715 new cases of cancer in children 0 to 14 years of age in Canada, an average of 943 cases per year. Between 2008 and 2012, there were 595 cancer deaths in children 0 to 14 years of age in Canada, an average of 119 deaths per year.

An average of 290 people in Canada between the ages of 15 and 29 die from cancer each year. Young men are more likely to die than young women in this age range.

  • Radiation therapy is a critical treatment for children with cancer and The Princess Margaret has the largest paediatric radiation program in Canada
  • As a partner with SickKids, Princess Margaret Cancer Centre participates in numerous Children’s Oncology Group clinical trials and is involved in leading research in the field

It is estimated that in 2017, 28,600 Canadians will be diagnosed with lung cancer.

  • 14,400 men will be diagnosed with lung cancer
  • 14,200 women will be diagnosed with lung cancer

More than half of soft tissue sarcomas begin in the arm or leg. In 2013, 1,255 Canadians were diagnosed with soft tissue sarcoma.

The Supportive Care Department at Princess Margaret Cancer Centre is an innovative global leader, supporting patients and families at all stages of the cancer trajectory. Through clinical care, research, education and international partnerships, we continue to pioneer new approaches for patients and caregivers as they cope with the impact of cancer.

With over 50 specialized staff working with each of The Princess Margaret oncology clinics, the program sees more than 2,000 patients a year. They treat physical and emotional symptoms, such as pain, depression and anxiety, and assist patients and their caregivers in managing the complexities of cancer and treatment. The program supports patients and their caregivers from the time of diagnosis, through survivorship, to the advanced stages of cancer.

Supportive Care aims to pursue continued growth and evolution in its three key areas:

  • Psychosocial Oncology
  • Palliative Care
  • Survivorship and Cancer Rehabilitation

As a global leader in patient education, The Princess Margaret offers programs that encourage and enable people with cancer, their caregivers and their families to become active participants in their cancer care. Providing an environment where patients and families feel safe to learn and ask questions is part of how we do this.

Through hospital-based services and online communities that promote self-management and improved quality of life in the hospital, at home and in the community, we help people, no matter where they are in their cancer experience, get the knowledge, skills and strategies they need to make informed decisions and healthy lifestyle choices—and cope with the many challenges that cancer brings.

We bring our expertise in health communication, adult education and theories of health behaviour change to all our Princess Margaret practitioners, working with them to develop educational resources, including patient-centred curricula, pamphlets and videos.

Our patient support includes:

  • Classes and programs
  • Community Connections
  • Patient & Family Library
  • Online education & support

Cancer is the leading cause of death in Canada and is responsible for 30 per cent of all deaths.

  • 1 out of 2 Canadians (49 per cent of men and 45 per cent of women) are expected to develop cancer during their lifetimes
  • 1 out of 4 Canadians (29 per cent of men and 24 per cent of women) is expected to die from cancer

In 2017, an estimated 206,200 new cases of cancer and 80,800 cancer deaths will occur Canada.

It is estimated that in 2017:

  • 103,100 Canadian men will be diagnosed with cancer
  • 103,200 Canadian women will be diagnosed with cancer
  • On average, 565 Canadians will be diagnosed with cancer every day

Lung, breast, colorectal and prostate cancer are the most common types of cancer in Canada (excluding non-melanoma skin cancer). Based on 2017 estimates:

  • These cancers account for over 50 per cent of all new cancer cases
  • Prostate cancer accounts for 21 per cent of all new cancer cases in men
  • Lung cancer accounts for 14 per cent of all new cases of cancer
  • Breast cancer accounts for about one-quarter (25 per cent) of all new cancer cases in women
  • Colorectal cancer accounts for 13 per cent of all new cancer cases

Source: Canadian Cancer Society

The Princess Margaret uses cutting-edge radiation technologies and has the capacity to treat over 8,000 patients every year. The Radiation Medicine Program at The Princess Margaret the largest of its kind in Canada and one of the largest in North America. A team of radiation oncologists, therapists, physicists and nurses support the assessment, planning, treatment and follow-up care for common, rare and complex forms of cancer. For more information about the Radiation Medicine Program at The Princess Margaret, click here.

Discovery Research

To achieve global impact, a scientific research institute requires world-class people, platforms and programs. The Campbell Family Cancer Research Institute at Princess Margaret Cancer Centre is fortunate that many top scientists have left their homes to come to Toronto because they believe that this is where they can have the most impact.

The Institute is building world-class research programs utilizing our expertise in the scientific platforms most vital for cancer research: mass spectrometry, flow cytometry, new drug discovery, genetic sequencing, biobanking and computational biology.

Breast – Metastatic, Hormone Receptor +, HER2+, Inflammatory, Triple Negative, Locally Advanced

Breast cancer is the second leading cause of cancer death in Canadian females, accounting for 13 per cent of all female cancer deaths. 1 in 8 Canadian women are expected to develop breast cancer in their lifetime and 1 in 31 will die from it.

Gynaecologic Cancers – Uterine, Cervical, Ovarian and Vulvar Cancer

In 2017, it is estimated that:

  • 1,550 Canadian women will be diagnosed with cervical cancer
  • 7,300 will be diagnosed with uterine cancer
  • 2,800 will be diagnosed with ovarian cancer

The most recent incidence statistics for other and unspecified female genital organ cancers are from 2013:

  • 955 Canadian women were diagnosed with other and unspecified female genital organ cancers

The most recent mortality statistics for other and unspecified female genital organ cancers are from 2013:

  • 280 Canadian women died from other and unspecified female genital organ cancers

Colon, Rectal and Gastrointestinal, Prostate, Testicular, Bladder, Kidney and Genitourinary Cancer

26,800 Canadians will be diagnosed with colorectal cancer in 2017, representing approximately 13 per cent of all new cancer cases in 2017.

  • 14,900 men will be diagnosed with colorectal cancer and 5,100 will die from it.
  • 11,900 women will be diagnosed with colorectal cancer and 4,300 will die from it

It is estimated that in 2017, 3,500 Canadians will be diagnosed with stomach cancer.

  • 2,200 men will be diagnosed with stomach cancer and 1,250 will die from it.
  • 1,300 women will be diagnosed with stomach cancer and 790 will die from it.

The five-year relative survival for stomach cancer is 25 per cent. This means that, on average, people diagnosed with stomach cancer are 25 per cent as likely to live 5 years (or more) after diagnosis as people in the general population who do not have cancer.

Prostate, Testicular, Bladder, Kidney and Genitourinary Cancers

Prostate Cancer:

21,300 men will be diagnosed with prostate cancer. This represents 21 per cent of all new cancer cases in men in 2017. 4,100 men will die from prostate cancer. This represents 10 per cent of all cancer deaths in men in 2017.

  • On average, 58 Canadian men will be diagnosed with prostate cancer every day
  • On average, 11 Canadian men will die from prostate cancer every day

Prostate cancer is the most common type of cancer among Canadian men, excluding non-melanoma skin cancer.

Testicular Cancer:

  • An estimated 1,100 Canadian men will be diagnosed with testicular cancer in 2017
  • An estimated 45 will die from the disease

Bladder:

It is estimated that in 2017:

  • 8,900 Canadians will be diagnosed with bladder cancer and 2,400 Canadians will die from bladder cancer
  • 6,700 men will be diagnosed with bladder cancer and 1,700 will die from it
  • 2,200 women will be diagnosed with bladder cancer and 680 will die from it

Kidney Cancer:

It is estimated that in 2017, 6,600 Canadians will be diagnosed with kidney cancer.

  • 4,200 men will be diagnosed with kidney cancer and 1,200 will die from it
  • 2,400 women will be diagnosed with kidney cancer and 670 will die from it

Pancreatic Cancer

It is estimated that in 2017:

  • 5,500 Canadians will be diagnosed with pancreatic cancer
  • 4,800 Canadians will die from pancreatic cancer
  • 2,800 men will be diagnosed with pancreatic cancer and 2,400 will die from it
  • 2,700 women will be diagnosed with pancreatic cancer and 2,400 will die from it

Pancreatic cancer is the fourth leading cause of cancer death in both sexes accounting for 6 per cent of all cancer deaths.

In Canada, the five-year net survival for pancreatic cancer is eight per cent. This means that, on average, about eight per cent of people diagnosed with pancreatic cancer will survive for at least five years.

Head and Neck, Brain, Central Nervous System, Eye, Skin and Melanoma, Endocrine Cancer

It is estimated that in 2017:

  • 3,000 Canadians will be diagnosed with brain and spinal cord cancer
  • 2,400 Canadians will die from brain and spinal cord cancer
  • 1,700 men will be diagnosed with brain and spinal cord cancer and 1,350 will die from it
  • 1,300 women will be diagnosed with brain and spinal cord cancer and 1,050 will die from it
  • An estimated 55,000 Canadians are living with brain tumours

Eye cancer is rare. From 2013, approximately 335 Canadians are diagnosed with eye cancer:

  • 175 men were diagnosed with eye cancer
  • 160 women were diagnosed with eye cancer

Skin Cancer & Melanoma

It is estimated that in 2017, 7,200 Canadians will be diagnosed with melanoma.

  • 4,000 men will be diagnosed with melanoma
  • 3,300 women will be diagnosed with melanoma
  • 80-90 per cent of skin cancer cases are caused by ultraviolet radiation

Endocrine Cancer

In 2010, 135 Canadians died from endocrine system related cancers. Because these cancers are so rare, prognosis is not well known.

Lymphoma, Leukaemia Cancer

Lymphoma

It is estimated that in 2017:

  • 990 Canadians will be diagnosed with Hodgkin lymphoma
  • 140 Canadians will die from Hodgkin lymphoma
  • 570 men will be diagnosed with Hodgkin lymphoma and 85 will die from it
  • 430 women will be diagnosed with Hodgkin lymphoma and 60 will die from it

It is estimated that in 2017:

  • 8,300 Canadians will be diagnosed with non-Hodgkin lymphoma
  • 2,700 Canadians will die from non-Hodgkin lymphoma
  • 4,600 men will be diagnosed with non-Hodgkin lymphoma and 1,500 will die from it
  • 3,700 women will be diagnosed with non-Hodgkin lymphoma and 1,200 will die from it

Leukaemia

It is estimated that in 2017:

  • 6,200 Canadians will be diagnosed with leukaemia
  • 2,900 Canadians will die from leukaemia
  • 3,600 men will be diagnosed with leukaemia and 1,650 will die from it
  • 2,600 women will be diagnosed with leukaemia and 1,250 will die from it

Childhood Cancer

Childhood cancer accounts for less than one per cent of all new cancer cases in Canada.

The three types of cancer that account for the majority of new cancer cases in children 0 to 14 years of age in Canada are:

  • Leukaemia – 32 per cent
  • Brain and central nervous system – 19 per cent
  • Lymphomas – 11 per cent

The three types of cancer that account for the majority of cancer death in children 0 to 14 years of age in Canada are:

  • Brain and central nervous system – 34 per cent
  • Leukaemia – 26 per cent
  • Neuroblastoma and other peripheral nervous cell tumours – 11 per cent

Childhood cancer is relatively uncommon. However, it remains the most common disease-related cause of death more than asthma, diabetes, cystic fibrosis and AIDS combined. It is second only to injury-related deaths among Canadian children. In 2012, cancer was the leading cause of disease-related death in children under the age of 15 years.

Between 2009 and 2013, there were 4,715 new cases of cancer in children 0 to 14 years of age in Canada, an average of 943 cases per year. Between 2008 and 2012, there were 595 cancer deaths in children 0 to 14 years of age in Canada, an average of 119 deaths per year.

An average of 290 people in Canada between the ages of 15 and 29 die from cancer each year. Young men are more likely to die than young women in this age range.

  • Radiation therapy is a critical treatment for children with cancer and The Princess Margaret has the largest paediatric radiation program in Canada
  • As a partner with SickKids, Princess Margaret Cancer Centre participates in numerous Children’s Oncology Group clinical trials and is involved in leading research in the field

Lung Cancer

It is estimated that in 2017, 28,600 Canadians will be diagnosed with lung cancer.

  • 14,400 men will be diagnosed with lung cancer
  • 14,200 women will be diagnosed with lung cancer

Sarcoma

More than half of soft tissue sarcomas begin in the arm or leg. In 2013, 1,255 Canadians were diagnosed with soft tissue sarcoma.

Supportive Care

The Supportive Care Department at Princess Margaret Cancer Centre is an innovative global leader, supporting patients and families at all stages of the cancer trajectory. Through clinical care, research, education and international partnerships, we continue to pioneer new approaches for patients and caregivers as they cope with the impact of cancer.

With over 50 specialized staff working with each of The Princess Margaret oncology clinics, the program sees more than 2,000 patients a year. They treat physical and emotional symptoms, such as pain, depression and anxiety, and assist patients and their caregivers in managing the complexities of cancer and treatment. The program supports patients and their caregivers from the time of diagnosis, through survivorship, to the advanced stages of cancer.

Supportive Care aims to pursue continued growth and evolution in its three key areas:

  • Psychosocial Oncology
  • Palliative Care
  • Survivorship and Cancer Rehabilitation

Patient Education

As a global leader in patient education, The Princess Margaret offers programs that encourage and enable people with cancer, their caregivers and their families to become active participants in their cancer care. Providing an environment where patients and families feel safe to learn and ask questions is part of how we do this.

Through hospital-based services and online communities that promote self-management and improved quality of life in the hospital, at home and in the community, we help people, no matter where they are in their cancer experience, get the knowledge, skills and strategies they need to make informed decisions and healthy lifestyle choices—and cope with the many challenges that cancer brings.

We bring our expertise in health communication, adult education and theories of health behaviour change to all our Princess Margaret practitioners, working with them to develop educational resources, including patient-centred curricula, pamphlets and videos.

Our patient support includes:

  • Classes and programs
  • Community Connections
  • Patient & Family Library
  • Online education & support

Cancer in Canada

Cancer is the leading cause of death in Canada and is responsible for 30 per cent of all deaths.

  • 1 out of 2 Canadians (49 per cent of men and 45 per cent of women) are expected to develop cancer during their lifetimes
  • 1 out of 4 Canadians (29 per cent of men and 24 per cent of women) is expected to die from cancer

In 2017, an estimated 206,200 new cases of cancer and 80,800 cancer deaths will occur Canada.

It is estimated that in 2017:

  • 103,100 Canadian men will be diagnosed with cancer
  • 103,200 Canadian women will be diagnosed with cancer
  • On average, 565 Canadians will be diagnosed with cancer every day

Lung, breast, colorectal and prostate cancer are the most common types of cancer in Canada (excluding non-melanoma skin cancer). Based on 2017 estimates:

  • These cancers account for over 50 per cent of all new cancer cases
  • Prostate cancer accounts for 21 per cent of all new cancer cases in men
  • Lung cancer accounts for 14 per cent of all new cases of cancer
  • Breast cancer accounts for about one-quarter (25 per cent) of all new cancer cases in women
  • Colorectal cancer accounts for 13 per cent of all new cancer cases

Source: Canadian Cancer Society

Radiation

The Princess Margaret uses cutting-edge radiation technologies and has the capacity to treat over 8,000 patients every year. The Radiation Medicine Program at The Princess Margaret the largest of its kind in Canada and one of the largest in North America. A team of radiation oncologists, therapists, physicists and nurses support the assessment, planning, treatment and follow-up care for common, rare and complex forms of cancer. For more information about the Radiation Medicine Program at The Princess Margaret, click here.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search